Mylotarg gemtuzumab zogamicin regulatory update

The FDA's Oncologic Drugs Advisory Committee will review on March 17 the partners' NDA for Mylotarg, a humanized antibody against CD33 linked to the calicheamicin cytotoxin, to treat CD33 positive re...